My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Targeting energy metabolism in brain cancer: review and hypothesis.

    Seyfried TN, Mukherjee P.

    Nutr Metab (Lond). 2005 Oct 21;2:30.PMID: 16242042 [PubMed]Related articlesFree article

    2.

    Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet.

    Seyfried BT, Kiebish M, Marsh J, Mukherjee P.

    J Cancer Res Ther. 2009 Sep;5 Suppl 1:S7-15.PMID: 20009300 [PubMed - in process]Related articlesFree article

    3.

    The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.

    Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN.

    Nutr Metab (Lond). 2007 Feb 21;4:5.PMID: 17313687 [PubMed]Related articlesFree article

    4.

    Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies.

    Greene AE, Todorova MT, Seyfried TN.

    J Neurochem. 2003 Aug;86(3):529-37. Review.PMID: 12859666 [PubMed - indexed for MEDLINE]Related articles

    5.

    Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

    Seyfried TN, Sanderson TM, El-Abbadi MM, McGowan R, Mukherjee P.

    Br J Cancer. 2003 Oct 6;89(7):1375-82.PMID: 14520474 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets.

    Seyfried TN, Kiebish M, Mukherjee P, Marsh J.

    Epilepsia. 2008 Nov;49 Suppl 8:114-6. Review.PMID: 19049606 [PubMed - indexed for MEDLINE]Related articles

    7.

    Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet.

    Marsh J, Mukherjee P, Seyfried TN.

    Nutr Metab (Lond). 2008 Nov 25;5:33.PMID: 19032781 [PubMed - in process]Related articlesFree article

    8.

    Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.

    Lefranc F, Rynkowski M, DeWitte O, Kiss R.

    Adv Tech Stand Neurosurg. 2009;34:3-35. Review.PMID: 19368079 [PubMed - indexed for MEDLINE]Related articles

    9.

    Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells.

    Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, Parslow D, Armistead S, Lemire K, Orrell J, Teich J, Chomicz S, Ferrick DA.

    Am J Physiol Cell Physiol. 2007 Jan;292(1):C125-36. Epub 2006 Sep 13.PMID: 16971499 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain.

    Mukherjee P, Mulrooney TJ, Marsh J, Blair D, Chiles TC, Seyfried TN.

    Mol Cancer. 2008 May 12;7:37.PMID: 18474106 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Ketone bodies inhibit the viability of human neuroblastoma cells.

    Skinner R, Trujillo A, Ma X, Beierle EA.

    J Pediatr Surg. 2009 Jan;44(1):212-6; discussion 216.PMID: 19159745 [PubMed - indexed for MEDLINE]Related articles

    12.

    Adaptation of energy metabolism in breast cancer brain metastases.

    Chen EI, Hewel J, Krueger JS, Tiraby C, Weber MR, Kralli A, Becker K, Yates JR 3rd, Felding-Habermann B.

    Cancer Res. 2007 Feb 15;67(4):1472-86.PMID: 17308085 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.

    Maalouf M, Rho JM, Mattson MP.

    Brain Res Rev. 2009 Mar;59(2):293-315. Epub 2008 Sep 25. Review.PMID: 18845187 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions.

    Haces ML, Hernández-Fonseca K, Medina-Campos ON, Montiel T, Pedraza-Chaverri J, Massieu L.

    Exp Neurol. 2008 May;211(1):85-96. Epub 2008 Jan 26.PMID: 18339375 [PubMed - indexed for MEDLINE]Related articles

    16.

    Neuroprotective and disease-modifying effects of the ketogenic diet.

    Gasior M, Rogawski MA, Hartman AL.

    Behav Pharmacol. 2006 Sep;17(5-6):431-9. Review.PMID: 16940764 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Energy balance, physical activity, and cancer risk.

    Fair AM, Montgomery K.

    Methods Mol Biol. 2009;472:57-88. Review.PMID: 19107429 [PubMed - indexed for MEDLINE]Related articles

    18.

    Availability of neurotransmitter glutamate is diminished when beta-hydroxybutyrate replaces glucose in cultured neurons.

    Lund TM, Risa O, Sonnewald U, Schousboe A, Waagepetersen HS.

    J Neurochem. 2009 Jul;110(1):80-91. Epub 2009 May 18.PMID: 19457063 [PubMed - indexed for MEDLINE]Related articles

    19.

    The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots.

    Costello LC, Franklin RB.

    Mol Cancer. 2006 May 15;5:17. Review.PMID: 16700911 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet.

    Ruskin DN, Kawamura M, Masino SA.

    PLoS One. 2009 Dec 23;4(12):e8349.PMID: 20041135 [PubMed - in process]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk